BENDAMUSTINE HCL

BENDAMUSTINE HCL was reported 15664 times

BENDAMUSTINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOLLICULAR LYMPHOMA REFRACTORY 27 0.4154
1 MARGINAL ZONE LYMPHOMA RECURRENT 17 0.3542
2 LYMPHATIC DUCT INJURY 7 0.3043
3 FOLLICULAR LYMPHOMA RECURRENT 13 0.1625
4 SPLEEN ATROPHY 9 0.1525
5 FOLLICULAR LYMPHOMA 128 0.1455
6 SPLENIC MARGINAL ZONE LYMPHOMA 11 0.1447
7 HUMORAL IMMUNE DEFECT 52 0.1402
8 CELL-MEDIATED CYTOTOXICITY 7 0.1373
9 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 302 0.1368
10 BLOOD IMMUNOGLOBULIN M ABNORMAL 14 0.1359
11 B-CELL LYMPHOMA RECURRENT 70 0.1289
12 MANTLE CELL LYMPHOMA RECURRENT 56 0.1287
13 FUNGAL DISEASE CARRIER 13 0.1287
14 URETERIC COMPRESSION 9 0.1184
15 B-CELL LYMPHOMA REFRACTORY 10 0.1124
16 LYMPHOMA TRANSFORMATION 38 0.1056
17 BLOOD IMMUNOGLOBULIN G ABNORMAL 16 0.0958
18 GASTROENTERITIS SAPOVIRUS 8 0.0920
19 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 61 0.0875
20 ENDOCARDITIS NONINFECTIVE 13 0.0872
21 RETICULOCYTOPENIA 12 0.0822
22 REFRACTORY CANCER 17 0.0794
23 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 7 0.0745
24 BLOOD STEM CELL HARVEST FAILURE 11 0.0743
25 MANTLE CELL LYMPHOMA 103 0.0676
26 DISSEMINATED TOXOPLASMOSIS 8 0.0667
27 VACCINE INTERACTION 20 0.0645
28 LEUKAEMIC INFILTRATION 9 0.0643
29 PARANEOPLASTIC PEMPHIGUS 8 0.0615
30 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 58 0.0612
31 LEUKAEMIA CUTIS 9 0.0584
32 PRIMARY AMYLOIDOSIS 15 0.0584
33 BREAKTHROUGH COVID-19 13 0.0565
34 HUMAN POLYOMAVIRUS INFECTION 30 0.0565
35 DIFFUSE LARGE B-CELL LYMPHOMA 421 0.0546
36 MARGINAL ZONE LYMPHOMA 11 0.0514
37 CELL-MEDIATED IMMUNE DEFICIENCY 7 0.0500
38 CYSTITIS VIRAL 19 0.0496
39 CANDIDA PNEUMONIA 16 0.0495
40 CYTOMEGALOVIRUS SYNDROME 8 0.0485
41 HIGH-GRADE B-CELL LYMPHOMA 8 0.0428
42 JC VIRUS INFECTION 68 0.0425
43 CAMPYLOBACTER INFECTION 35 0.0421
44 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 322 0.0390
45 GRANULOMATOUS LYMPHADENITIS 7 0.0374
46 BLOOD LACTATE DEHYDROGENASE ABNORMAL 25 0.0369
47 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 12 0.0366
48 CYTOMEGALOVIRUS INFECTION REACTIVATION 159 0.0360
49 NEUTROPENIC INFECTION 34 0.0355
50 ILIUM FRACTURE 7 0.0341
51 CAMPYLOBACTER GASTROENTERITIS 20 0.0337
52 BONE MARROW INFILTRATION 13 0.0336
53 LENTIGO MALIGNA 9 0.0336
54 HYPERTENSIVE CARDIOMYOPATHY 9 0.0324
55 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 19 0.0320
56 BLOOD URIC ACID ABNORMAL 13 0.0319
57 CHRONIC LYMPHOCYTIC LEUKAEMIA 151 0.0318
58 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 7 0.0304
59 CYTOMEGALOVIRUS OESOPHAGITIS 11 0.0299
60 PNEUMONIA ESCHERICHIA 10 0.0294
61 CEREBRAL ASPERGILLOSIS 18 0.0293
62 CATHETER SITE THROMBOSIS 8 0.0292
63 CONGENITAL APLASIA 9 0.0289
64 ABDOMINAL LYMPHADENOPATHY 25 0.0288
65 HYPOGAMMAGLOBULINAEMIA 188 0.0286
66 BORRELIA INFECTION 9 0.0286
67 DISSEMINATED MUCORMYCOSIS 11 0.0279
68 HYPERVISCOSITY SYNDROME 8 0.0278
69 ENCEPHALITIS CYTOMEGALOVIRUS 12 0.0274
70 INTERLEUKIN LEVEL INCREASED 15 0.0272
71 CYTOMEGALOVIRUS CHORIORETINITIS 53 0.0272
72 CRYOGLOBULINAEMIA 19 0.0266
73 LISTERIA SEPSIS 7 0.0265
74 HYPERLEUKOCYTOSIS 23 0.0260
75 SKIN NEOPLASM EXCISION 20 0.0255
76 CENTRAL NERVOUS SYSTEM NECROSIS 7 0.0255
77 HEPATITIS E 40 0.0253
78 CYTOMEGALOVIRUS ENTERITIS 9 0.0253
79 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 9 0.0248
80 RETROPERITONEAL LYMPHADENOPATHY 13 0.0247
81 LYMPHOMA 373 0.0241
82 VACCINATION FAILURE 40 0.0240
83 PROCALCITONIN INCREASED 28 0.0239
84 BLOOD LACTATE DEHYDROGENASE INCREASED 377 0.0238
85 PNEUMONIA PSEUDOMONAL 36 0.0235
86 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 14 0.0233
87 HEPATITIS B REACTIVATION 73 0.0230
88 CYTOMEGALOVIRUS HEPATITIS 8 0.0226
89 GRANULOMA SKIN 18 0.0219
90 PLASMA CELL LEUKAEMIA 13 0.0217
91 IMMUNOGLOBULINS DECREASED 29 0.0211
92 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 125 0.0211
93 TUMOUR LYSIS SYNDROME 185 0.0210
94 SECONDARY IMMUNODEFICIENCY 25 0.0206
95 ANGIOCENTRIC LYMPHOMA 10 0.0203
96 VARICELLA ZOSTER VIRUS INFECTION 42 0.0202
97 HEPATITIS VIRAL 16 0.0199
98 B-CELL LYMPHOMA 67 0.0197
99 DYSPLASTIC NAEVUS 7 0.0194
100 DISEASE PROGRESSION 2269 0.0192
101 TUMOUR FLARE 13 0.0190
102 ACETABULUM FRACTURE 7 0.0187
103 PNEUMOCYSTIS JIROVECII INFECTION 22 0.0184
104 CYTOKINE RELEASE SYNDROME 367 0.0183
105 LIPID METABOLISM DISORDER 7 0.0182
106 CYTOMEGALOVIRUS INFECTION 298 0.0179
107 METASTATIC LYMPHOMA 7 0.0179
108 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 15 0.0178
109 GASTROINTESTINAL FUNGAL INFECTION 9 0.0175
110 NEUROENDOCRINE CARCINOMA OF THE SKIN 17 0.0174
111 SERUM SICKNESS 47 0.0168
112 INFECTION REACTIVATION 19 0.0166
113 PNEUMONIA CYTOMEGALOVIRAL 32 0.0165
114 PLASMA CELL MYELOMA REFRACTORY 22 0.0164
115 CYTOPENIA 201 0.0164
116 BLINDNESS CORTICAL 8 0.0163
117 HAEMATOTOXICITY 155 0.0163
118 CEREBRAL TOXOPLASMOSIS 15 0.0161
119 ENTEROCOCCAL SEPSIS 13 0.0160
120 HYPERCREATININAEMIA 8 0.0159
121 PANNICULITIS 38 0.0157
122 COVID-19 PNEUMONIA 181 0.0153
123 CHYLOTHORAX 11 0.0153
124 MYELOPROLIFERATIVE NEOPLASM 10 0.0151
125 NEUTROPENIC SEPSIS 106 0.0148
126 CYTOKINE STORM 10 0.0146
127 CYTOMEGALOVIRUS TEST POSITIVE 26 0.0146
128 BLOOD BILIRUBIN DECREASED 9 0.0146
129 POST-ACUTE COVID-19 SYNDROME 18 0.0145
130 ENTEROCOCCAL INFECTION 70 0.0145
131 CYTOMEGALOVIRUS COLITIS 33 0.0143
132 ANOSOGNOSIA 11 0.0143
133 KLEBSIELLA SEPSIS 16 0.0142
134 ENTEROCOCCAL BACTERAEMIA 15 0.0142
135 OTOTOXICITY 26 0.0140
136 SINUS POLYP 8 0.0139
137 HEPATITIS B 83 0.0138
138 PNEUMOCOCCAL SEPSIS 9 0.0137
139 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 17 0.0136
140 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 8 0.0135
141 NEOPLASM SKIN 21 0.0135
142 THERAPY PARTIAL RESPONDER 210 0.0134
143 ABDOMINAL NEOPLASM 12 0.0134
144 RESORPTION BONE INCREASED 11 0.0134
145 AUTOIMMUNE HAEMOLYTIC ANAEMIA 45 0.0131
146 HEMIANOPIA 13 0.0131
147 MYELODYSPLASTIC SYNDROME 188 0.0130
148 FEBRILE INFECTION 15 0.0127
149 PNEUMONIA MYCOPLASMAL 10 0.0126
150 HERPES ZOSTER DISSEMINATED 10 0.0125
151 HYPERURICAEMIA 51 0.0124
152 PLASMACYTOMA 23 0.0123
153 FEBRILE NEUTROPENIA 808 0.0122
154 LYMPHOPENIA 172 0.0121
155 BLOOD PARATHYROID HORMONE DECREASED 18 0.0121
156 PERIPHERAL MOTOR NEUROPATHY 17 0.0121
157 LYMPHOCYTOSIS 26 0.0121
158 ENTEROCOLITIS INFECTIOUS 11 0.0119
159 TUMOUR PSEUDOPROGRESSION 13 0.0119
160 BONE MARROW TOXICITY 14 0.0118
161 PNEUMOTHORAX SPONTANEOUS 8 0.0118
162 BLOOD IMMUNOGLOBULIN M INCREASED 7 0.0115
163 CLEAR CELL RENAL CELL CARCINOMA 8 0.0115
164 ENCEPHALITIS VIRAL 14 0.0115
165 PEPTIC ULCER HAEMORRHAGE 8 0.0115
166 ASPERGILLUS INFECTION 75 0.0114
167 FUNGAL OESOPHAGITIS 8 0.0113
168 PNEUMOCYSTIS JIROVECII PNEUMONIA 114 0.0113
169 APLASIA PURE RED CELL 39 0.0113
170 APLASIA 22 0.0112
171 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 31 0.0112
172 VASOGENIC CEREBRAL OEDEMA 8 0.0111
173 VISCERAL LEISHMANIASIS 8 0.0111
174 ESCHERICHIA BACTERAEMIA 26 0.0110
175 BACTERIAL DISEASE CARRIER 8 0.0110
176 DYSPLASIA 13 0.0108
177 KLEBSIELLA TEST POSITIVE 7 0.0108
178 NEOPLASM RECURRENCE 36 0.0106
179 PELVIC VENOUS THROMBOSIS 15 0.0105
180 PNEUMONIA FUNGAL 41 0.0104
181 BRONCHOPULMONARY ASPERGILLOSIS 80 0.0103
182 LUNG ADENOCARCINOMA 31 0.0103
183 PULMONARY MYCOSIS 8 0.0103
184 HILAR LYMPHADENOPATHY 9 0.0102
185 ATYPICAL PNEUMONIA 30 0.0100
186 H1N1 INFLUENZA 14 0.0100
187 LISTERIOSIS 11 0.0099
188 MUCOSAL EROSION 9 0.0099
189 LYMPHOCYTE COUNT DECREASED 173 0.0098
190 FAT TISSUE INCREASED 14 0.0096
191 SECOND PRIMARY MALIGNANCY 79 0.0095
192 DERMATITIS EXFOLIATIVE GENERALISED 33 0.0095
193 HYPERCALCAEMIA 115 0.0093
194 ADENOCARCINOMA OF COLON 17 0.0091
195 METASTASIS 63 0.0088
196 SUBCLAVIAN VEIN THROMBOSIS 10 0.0088
197 NEUTROPENIA 1185 0.0087
198 BONE MARROW DISORDER 26 0.0086
199 THROMBOCYTOPENIA 959 0.0086
200 ANAEMIA HAEMOLYTIC AUTOIMMUNE 7 0.0085
201 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 11 0.0084
202 ACTINOMYCOSIS 8 0.0084
203 METASTASES TO MENINGES 19 0.0083
204 PANCYTOPENIA 463 0.0083
205 ACINETOBACTER INFECTION 9 0.0082
206 SKIN TOXICITY 46 0.0081
207 PERIPHERAL NERVE INJURY 7 0.0080
208 PNEUMONIA BACTERIAL 73 0.0079
209 CD4 LYMPHOCYTES DECREASED 17 0.0079
210 ESCHERICHIA SEPSIS 23 0.0079
211 LYMPHADENITIS 19 0.0078
212 PNEUMONIA VIRAL 25 0.0078
213 OSTEOLYSIS 16 0.0078
214 HEPATOSPLENOMEGALY 20 0.0078
215 DEMYELINATING POLYNEUROPATHY 8 0.0078
216 CAROTID ARTERIOSCLEROSIS 8 0.0078
217 PLASMA CELL MYELOMA 302 0.0077
218 SYSTEMIC MYCOSIS 9 0.0077
219 MALIGNANT PLEURAL EFFUSION 13 0.0077
220 SOFT TISSUE INFECTION 14 0.0076
221 ACUTE MYELOID LEUKAEMIA 119 0.0076
222 FUNGAEMIA 12 0.0076
223 PULMONARY SEPSIS 11 0.0076
224 ORGANISING PNEUMONIA 37 0.0075
225 GUILLAIN-BARRE SYNDROME 36 0.0074
226 ORAL FUNGAL INFECTION 20 0.0073
227 JUGULAR VEIN THROMBOSIS 13 0.0073
228 GASTROINTESTINAL TOXICITY 35 0.0073
229 SYSTEMIC INFECTION 12 0.0072
230 HYDRONEPHROSIS 54 0.0072
231 PNEUMOCYSTIS JIROVECI PNEUMONIA 16 0.0072
232 SQUAMOUS CELL CARCINOMA OF SKIN 43 0.0071
233 TROPONIN T INCREASED 9 0.0071
234 GRANULOCYTE COUNT DECREASED 13 0.0070
235 BILIARY OBSTRUCTION 9 0.0069
236 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 16 0.0069
237 LYMPHADENOPATHY MEDIASTINAL 13 0.0068
238 SYSTEMIC CANDIDA 17 0.0068
239 POLYNEUROPATHY 81 0.0068
240 PSEUDOMONAS INFECTION 58 0.0068
241 LYMPHADENOPATHY 239 0.0067
242 ESCHERICHIA URINARY TRACT INFECTION 28 0.0066
243 RHEUMATOID NODULE 18 0.0065
244 BONE MARROW FAILURE 132 0.0065
245 NEUROLOGICAL DECOMPENSATION 15 0.0065
246 ARRHYTHMIA SUPRAVENTRICULAR 7 0.0064
247 HISTIOCYTOSIS HAEMATOPHAGIC 19 0.0064
248 VENOOCCLUSIVE DISEASE 16 0.0064
249 OTITIS MEDIA 21 0.0064
250 NEUTROPENIC COLITIS 13 0.0063
251 CARDIAC HYPERTROPHY 7 0.0063
252 PSEUDOMONAL SEPSIS 11 0.0063
253 NEOPLASM 72 0.0063
254 ADENOCARCINOMA 14 0.0062
255 BACTERAEMIA 74 0.0062
256 CLOSTRIDIUM DIFFICILE COLITIS 66 0.0062
257 BASAL CELL CARCINOMA 96 0.0061
258 KLEBSIELLA INFECTION 31 0.0061
259 NON-HODGKIN'S LYMPHOMA 8 0.0061
260 NEPHROGENIC DIABETES INSIPIDUS 7 0.0061
261 OSTEOCHONDROSIS 7 0.0060
262 SEPTIC SHOCK 261 0.0060
263 SPLENOMEGALY 70 0.0060
264 ESCHERICHIA INFECTION 49 0.0060
265 HAEMOLYTIC ANAEMIA 53 0.0059
266 RHINOVIRUS INFECTION 23 0.0059
267 GRAFT VERSUS HOST DISEASE IN SKIN 13 0.0059
268 NOCARDIOSIS 15 0.0059
269 LEUKOPENIA 293 0.0059
270 PSEUDOMEMBRANOUS COLITIS 13 0.0058
271 RETINITIS 10 0.0058
272 HYPOALBUMINAEMIA 45 0.0058
273 CLOSTRIDIUM COLITIS 7 0.0058
274 SUSPECTED OFF LABEL USE 26 0.0057
275 OSTEOSCLEROSIS 9 0.0057
276 PARAPARESIS 10 0.0056
277 MYELOSUPPRESSION 202 0.0056
278 INTRADUCTAL PROLIFERATIVE BREAST LESION 7 0.0056
279 NEOPLASM PROGRESSION 192 0.0055
280 OESOPHAGEAL CANDIDIASIS 22 0.0055
281 NEUTROPHIL COUNT DECREASED 225 0.0055
282 AGRANULOCYTOSIS 101 0.0054
283 UROSEPSIS 50 0.0054
284 GASTROINTESTINAL OBSTRUCTION 13 0.0054
285 RASH MACULO-PAPULAR 120 0.0054
286 ADJUSTMENT DISORDER 7 0.0054
287 INFECTED SKIN ULCER 10 0.0053
288 INFECTIOUS PLEURAL EFFUSION 8 0.0053
289 BLOOD IMMUNOGLOBULIN G DECREASED 13 0.0052
290 MUCOSAL INFLAMMATION 137 0.0052
291 GENITAL HERPES 8 0.0052
292 BACTERIAL SEPSIS 17 0.0052
293 ACUTE SINUSITIS 9 0.0052
294 CYTOMEGALOVIRUS VIRAEMIA 23 0.0052
295 TOXIC SKIN ERUPTION 52 0.0052
296 PERIPHERAL SENSORY NEUROPATHY 30 0.0051
297 PNEUMONITIS 139 0.0051
298 SQUAMOUS CELL CARCINOMA 48 0.0051
299 CENTRAL NERVOUS SYSTEM LYMPHOMA 7 0.0051
300 CYSTITIS HAEMORRHAGIC 20 0.0050
301 BREATH SOUNDS ABNORMAL 24 0.0049
302 INFLAMMATORY MARKER INCREASED 24 0.0048
303 CAPILLARY LEAK SYNDROME 10 0.0048
304 SKIN NECROSIS 25 0.0048
305 TACHYARRHYTHMIA 12 0.0048
306 NEUROTOXICITY 84 0.0048
307 BRAIN ABSCESS 12 0.0047
308 LEUKAEMIA RECURRENT 8 0.0047
309 SPLEEN DISORDER 8 0.0047
310 MONOCYTE COUNT INCREASED 17 0.0047
311 LUNG CONSOLIDATION 13 0.0046
312 GENE MUTATION 9 0.0045
313 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 34 0.0045
314 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 23 0.0045
315 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 12 0.0045
316 PARESIS 10 0.0045
317 HERPES SIMPLEX 29 0.0045
318 STAPHYLOCOCCAL SEPSIS 22 0.0045
319 VENOOCCLUSIVE LIVER DISEASE 22 0.0045
320 THERAPY NON-RESPONDER 200 0.0044
321 ATRIAL FLUTTER 35 0.0044
322 QUADRIPLEGIA 9 0.0044
323 NEPHROPATHY TOXIC 49 0.0044
324 VENTRICULAR HYPOKINESIA 14 0.0044
325 URINARY TRACT INFECTION BACTERIAL 11 0.0043
326 OPPORTUNISTIC INFECTION 8 0.0043
327 CANDIDA INFECTION 73 0.0043
328 COVID-19 752 0.0043
329 HAEMOLYSIS 33 0.0043
330 SEPSIS 476 0.0043
331 NEUTROPHIL COUNT ABNORMAL 12 0.0042
332 BACTERIAL INFECTION 79 0.0042
333 C-REACTIVE PROTEIN INCREASED 154 0.0042
334 LEFT VENTRICULAR DYSFUNCTION 28 0.0042
335 ERYSIPELAS 21 0.0042
336 LUNG OPACITY 11 0.0042
337 GRAFT VERSUS HOST DISEASE 30 0.0042
338 DRUG RESISTANCE 107 0.0042
339 ENTEROCOLITIS 24 0.0042
340 BLOOD CREATININE DECREASED 13 0.0041
341 HEPATORENAL SYNDROME 7 0.0041
342 ABDOMINAL MASS 11 0.0041
343 INFECTION 594 0.0041
344 MALIGNANT NEOPLASM PROGRESSION 419 0.0041
345 ANAEMIA 780 0.0041
346 LYMPHOPROLIFERATIVE DISORDER 12 0.0041
347 AMYLOIDOSIS 7 0.0041
348 BLOOD CREATININE ABNORMAL 14 0.0040
349 ENCEPHALITIS 28 0.0040
350 CARDIAC DYSFUNCTION 15 0.0040
351 TYPE IV HYPERSENSITIVITY REACTION 11 0.0040
352 BLOOD DISORDER 32 0.0040
353 EMBOLISM 33 0.0040
354 METASTASES TO PERITONEUM 10 0.0040
355 INFUSION RELATED REACTION 258 0.0039
356 ACTINIC KERATOSIS 10 0.0038
357 MULTIPLE ORGAN DYSFUNCTION SYNDROME 109 0.0038
358 SKIN INFECTION 43 0.0038
359 VENOUS THROMBOSIS 15 0.0038
360 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 19 0.0038
361 IMMUNE-MEDIATED ENTEROCOLITIS 14 0.0038
362 DERMATITIS EXFOLIATIVE 19 0.0038
363 NON-CARDIAC CHEST PAIN 12 0.0038
364 FEBRILE BONE MARROW APLASIA 16 0.0038
365 GASTROINTESTINAL STROMAL TUMOUR 10 0.0038
366 AREFLEXIA 10 0.0037
367 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 29 0.0037
368 CHRONIC SINUSITIS 14 0.0037
369 HUMAN HERPESVIRUS 6 INFECTION 7 0.0037
370 LIVER ABSCESS 12 0.0037
371 NEUROLOGICAL SYMPTOM 21 0.0037
372 RED CELL DISTRIBUTION WIDTH INCREASED 15 0.0036
373 SPINAL COLUMN INJURY 8 0.0036
374 RENAL TUBULAR NECROSIS 35 0.0036
375 BK VIRUS INFECTION 12 0.0036
376 NON-SMALL CELL LUNG CANCER 17 0.0035
377 CLOSTRIDIAL INFECTION 12 0.0035
378 NECK MASS 10 0.0035
379 BRONCHOPNEUMONIA 12 0.0035
380 CACHEXIA 18 0.0035
381 SKIN MASS 23 0.0034
382 PLASMA CELL MYELOMA RECURRENT 11 0.0034
383 PROTEIN TOTAL INCREASED 9 0.0034
384 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 7 0.0034
385 VARICELLA 8 0.0033
386 ATRIAL TACHYCARDIA 7 0.0033
387 LARGE INTESTINAL ULCER 9 0.0033
388 RHEUMATOID FACTOR POSITIVE 19 0.0033
389 PROSTATITIS 10 0.0033
390 IMMUNE THROMBOCYTOPENIA 15 0.0033
391 GLOMERULAR FILTRATION RATE DECREASED 40 0.0033
392 EXOPHTHALMOS 7 0.0033
393 INTENTIONAL PRODUCT USE ISSUE 284 0.0032
394 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
395 CARDIOMYOPATHY 47 0.0032
396 COLITIS 120 0.0032
397 LUNG INFECTION 49 0.0032
398 CHOLESTATIC LIVER INJURY 7 0.0031
399 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 12 0.0031
400 EOSINOPHILIA 55 0.0031
401 ERYTHEMA NODOSUM 11 0.0031
402 PHLEBITIS 16 0.0031
403 OESOPHAGEAL ULCER 12 0.0031
404 HYPOPHOSPHATAEMIA 23 0.0031
405 ADENOVIRUS INFECTION 9 0.0031
406 METABOLIC DISORDER 18 0.0031
407 NEUROPATHY PERIPHERAL 294 0.0031
408 DISEASE RECURRENCE 147 0.0031
409 HEPATITIS TOXIC 8 0.0031
410 HEPATIC CYTOLYSIS 39 0.0031
411 PYREXIA 1056 0.0030
412 HAEMOLYTIC URAEMIC SYNDROME 7 0.0030
413 CARDIAC FAILURE ACUTE 20 0.0030
414 DRUG TOLERANCE 15 0.0030
415 C-REACTIVE PROTEIN ABNORMAL 19 0.0030
416 SHOCK HAEMORRHAGIC 24 0.0029
417 HEPATIC CYST 10 0.0029
418 LUNG INFILTRATION 26 0.0029
419 PROTEIN TOTAL DECREASED 11 0.0029
420 GENERALISED OEDEMA 36 0.0029
421 HYPERTHERMIA 22 0.0029
422 BRONCHITIS CHRONIC 7 0.0029
423 CHOLESTASIS 55 0.0029
424 FUNGAL INFECTION 95 0.0028
425 HERPES ZOSTER 163 0.0028
426 HAEMATOCRIT DECREASED 56 0.0028
427 BLOOD URIC ACID INCREASED 16 0.0028
428 PATHOLOGICAL FRACTURE 14 0.0028
429 IMMUNODEFICIENCY 41 0.0027
430 ABDOMINAL INFECTION 7 0.0027
431 EPSTEIN-BARR VIRUS INFECTION 17 0.0027
432 PLATELET COUNT DECREASED 290 0.0027
433 DRUG ERUPTION 48 0.0027
434 ACUTE RESPIRATORY FAILURE 52 0.0027
435 FAILURE TO THRIVE 14 0.0027
436 LEUKOENCEPHALOPATHY 10 0.0027
437 APLASTIC ANAEMIA 14 0.0027
438 ANGIOPATHY 15 0.0027
439 ASPARTATE AMINOTRANSFERASE INCREASED 142 0.0027
440 VASCULITIS 31 0.0027
441 RENAL CELL CARCINOMA 13 0.0027
442 ILEUS 33 0.0027
443 HEPATIC NECROSIS 10 0.0027
444 PNEUMONIA 857 0.0026
445 PLEURAL EFFUSION 161 0.0026
446 ATRIAL FIBRILLATION 254 0.0026
447 VIRAL LOAD INCREASED 10 0.0026
448 THROMBOPHLEBITIS 9 0.0026
449 BRONCHIOLITIS 9 0.0026
450 ACUTE RESPIRATORY DISTRESS SYNDROME 45 0.0025
451 CHOLECYSTITIS INFECTIVE 7 0.0025
452 TRANSAMINASES INCREASED 56 0.0025
453 PULMONARY FUNCTION TEST DECREASED 11 0.0025
454 IMMUNOSUPPRESSION 22 0.0025
455 CHRONIC GRAFT VERSUS HOST DISEASE 9 0.0025
456 HERPES VIRUS INFECTION 14 0.0024
457 ALANINE AMINOTRANSFERASE INCREASED 149 0.0024
458 ACUTE GRAFT VERSUS HOST DISEASE 11 0.0024
459 RESPIRATORY FAILURE 175 0.0024
460 WHITE BLOOD CELL COUNT DECREASED 260 0.0024
461 OFF LABEL USE 2085 0.0024
462 RESPIRATORY TRACT INFECTION 62 0.0024
463 BLOOD CREATININE INCREASED 155 0.0024
464 GENERAL PHYSICAL CONDITION ABNORMAL 16 0.0024
465 PERFORMANCE STATUS DECREASED 11 0.0024
466 CARDIOTOXICITY 21 0.0024
467 NEUTROPHIL COUNT INCREASED 24 0.0023
468 PLATELET COUNT ABNORMAL 14 0.0023
469 HYPERTRANSAMINASAEMIA 16 0.0023
470 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 59 0.0023
471 PROSTATOMEGALY 9 0.0023
472 GENERAL PHYSICAL HEALTH DETERIORATION 264 0.0023
473 AZOTAEMIA 9 0.0023
474 HEPATOTOXICITY 50 0.0022
475 APPENDICECTOMY 8 0.0022
476 ORGAN FAILURE 9 0.0022
477 BLOOD BILIRUBIN INCREASED 60 0.0022
478 HYPERNATRAEMIA 11 0.0022
479 RECURRENT CANCER 9 0.0022
480 VASCULAR DEVICE INFECTION 10 0.0022
481 WHITE BLOOD CELL COUNT ABNORMAL 14 0.0022
482 HAEMOGLOBIN ABNORMAL 14 0.0022
483 HYPOKALAEMIA 100 0.0022
484 HYPOMAGNESAEMIA 30 0.0022
485 ACUTE KIDNEY INJURY 328 0.0021
486 CARDIAC FAILURE 172 0.0021
487 PULMONARY FIBROSIS 41 0.0021
488 HEPATOMEGALY 21 0.0021
489 DISSEMINATED INTRAVASCULAR COAGULATION 30 0.0021
490 HYPERPYREXIA 9 0.0021
491 PULMONARY TOXICITY 15 0.0021
492 RHINITIS 17 0.0021
493 HYPOTONIA 21 0.0021
494 HYPOVOLAEMIC SHOCK 10 0.0021
495 INTERSTITIAL LUNG DISEASE 101 0.0021
496 SERUM FERRITIN INCREASED 11 0.0021
497 HEPATIC LESION 9 0.0021
498 RED BLOOD CELL SEDIMENTATION RATE INCREASED 23 0.0021
499 ELECTROLYTE IMBALANCE 24 0.0021
500 THROMBOTIC MICROANGIOPATHY 20 0.0021
501 HYPOVOLAEMIA 12 0.0020
502 LEFT VENTRICULAR FAILURE 7 0.0020
503 DIABETIC NEUROPATHY 10 0.0020
504 HYPOXIA 71 0.0020
505 BODY TEMPERATURE INCREASED 41 0.0020
506 MASS 28 0.0020
507 LEUKOCYTOSIS 36 0.0020
508 HYPERKALAEMIA 69 0.0020
509 ACUTE PULMONARY OEDEMA 11 0.0020
510 SUBDURAL HAEMATOMA 28 0.0020
511 GOITRE 8 0.0020
512 ULCER 31 0.0019
513 MENINGITIS 13 0.0019
514 MULTIPLE MYELOMA 9 0.0019
515 GRANULOCYTOPENIA 11 0.0019
516 HYPERBILIRUBINAEMIA 20 0.0019
517 BRONCHIECTASIS 13 0.0019
518 PULMONARY HAEMORRHAGE 15 0.0019
519 HEPATITIS C 23 0.0019
520 ACUTE HEPATIC FAILURE 26 0.0019
521 CHILLS 221 0.0019
522 AORTIC VALVE INCOMPETENCE 8 0.0019
523 SUBCUTANEOUS ABSCESS 9 0.0019
524 CARDIAC FAILURE CHRONIC 8 0.0019
525 ENTERITIS 12 0.0019
526 INTESTINAL PERFORATION 21 0.0019
527 GINGIVITIS 10 0.0019
528 SKIN REACTION 26 0.0018
529 POLYURIA 15 0.0018
530 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 100 0.0018
531 PETECHIAE 19 0.0018
532 ABDOMINAL ABSCESS 8 0.0018
533 FLUID INTAKE REDUCED 9 0.0018
534 HEPATITIS 46 0.0018
535 CARDIOPULMONARY FAILURE 7 0.0018
536 GASTROINTESTINAL INFECTION 16 0.0018
537 GASTROENTERITIS 26 0.0018
538 COLITIS ISCHAEMIC 12 0.0018
539 METASTASES TO LYMPH NODES 12 0.0018
540 ORAL DISORDER 13 0.0018
541 ATAXIA 21 0.0018
542 ILL-DEFINED DISORDER 107 0.0018
543 ATELECTASIS 17 0.0018
544 CEREBRAL ISCHAEMIA 9 0.0017
545 NIGHT SWEATS 56 0.0017
546 RESPIRATORY SYNCYTIAL VIRUS INFECTION 15 0.0017
547 PRESCRIBED UNDERDOSE 34 0.0017
548 HYPERGLYCAEMIA 62 0.0017
549 ANAPHYLACTOID REACTION 7 0.0017
550 PURPURA 15 0.0017
551 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
552 SARCOIDOSIS 8 0.0017
553 CONGESTIVE CARDIOMYOPATHY 7 0.0017
554 ODYNOPHAGIA 10 0.0017
555 ORAL CANDIDIASIS 22 0.0017
556 TUBULOINTERSTITIAL NEPHRITIS 31 0.0017
557 INGUINAL HERNIA 10 0.0016
558 MALIGNANT MELANOMA 22 0.0016
559 ENCEPHALOPATHY 40 0.0016
560 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
561 UPPER RESPIRATORY TRACT INFECTION 75 0.0016
562 STREPTOCOCCAL INFECTION 9 0.0016
563 OLIGURIA 10 0.0016
564 DEAFNESS 42 0.0016
565 SKIN LESION 44 0.0016
566 DIVERTICULUM INTESTINAL 7 0.0016
567 HAEMOGLOBIN DECREASED 164 0.0016
568 END STAGE RENAL DISEASE 29 0.0016
569 HYPOCALCAEMIA 30 0.0016
570 ASCITES 46 0.0016
571 MULTI-ORGAN FAILURE 27 0.0016
572 HEPATOCELLULAR INJURY 22 0.0016
573 DERMATITIS 32 0.0015
574 FACIAL PARALYSIS 13 0.0015
575 POLYARTHRITIS 8 0.0015
576 CHRONIC MYELOID LEUKAEMIA 7 0.0015
577 PNEUMOTHORAX 24 0.0015
578 CORONAVIRUS INFECTION 10 0.0015
579 HYPOTENSION 302 0.0015
580 VIRAL INFECTION 50 0.0015
581 DERMATITIS ACNEIFORM 9 0.0015
582 BEHAVIOUR DISORDER 8 0.0015
583 RENAL FAILURE 196 0.0015
584 PERICARDIAL EFFUSION 34 0.0015
585 STOMATITIS 89 0.0015
586 HEPATIC FAILURE 44 0.0015
587 ISCHAEMIC STROKE 26 0.0015
588 CONJUNCTIVITIS 27 0.0015
589 PRODUCT USE IN UNAPPROVED INDICATION 358 0.0014
590 NECROSIS 8 0.0014
591 ANAPHYLACTIC SHOCK 37 0.0014
592 BLOOD SODIUM DECREASED 27 0.0014
593 LUNG DISORDER 70 0.0014
594 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
595 NASAL POLYPS 7 0.0014
596 EJECTION FRACTION DECREASED 22 0.0014
597 BRONCHOSPASM 20 0.0014
598 ACUTE MYOCARDIAL INFARCTION 41 0.0014
599 BLOOD ALBUMIN DECREASED 11 0.0014
600 NODULE 18 0.0014
601 DEEP VEIN THROMBOSIS 89 0.0014
602 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
603 STAPHYLOCOCCAL INFECTION 44 0.0013
604 ACUTE CORONARY SYNDROME 11 0.0013
605 MITRAL VALVE INCOMPETENCE 15 0.0013
606 ECCHYMOSIS 9 0.0013
607 METASTASES TO LIVER 23 0.0013
608 COMPRESSION FRACTURE 7 0.0013
609 PULMONARY EMBOLISM 124 0.0013
610 STEVENS-JOHNSON SYNDROME 29 0.0013
611 SMALL INTESTINAL OBSTRUCTION 16 0.0013
612 DEVICE RELATED INFECTION 20 0.0013
613 ANAL ABSCESS 7 0.0013
614 RENAL IMPAIRMENT 109 0.0013
615 LOWER RESPIRATORY TRACT INFECTION 59 0.0013
616 CYSTITIS 41 0.0013
617 HEPATIC ENCEPHALOPATHY 12 0.0013
618 LIVER DISORDER 57 0.0013
619 NONSPECIFIC REACTION 7 0.0013
620 DERMATITIS ALLERGIC 16 0.0013
621 RETINAL HAEMORRHAGE 9 0.0013
622 JAUNDICE 34 0.0013
623 DRUG INTOLERANCE 122 0.0013
624 CHOLECYSTITIS 15 0.0013
625 INTRACRANIAL PRESSURE INCREASED 7 0.0013
626 GROIN PAIN 11 0.0013
627 VENTRICULAR EXTRASYSTOLES 13 0.0013
628 MALNUTRITION 14 0.0013
629 TENDERNESS 13 0.0012
630 SINUS BRADYCARDIA 12 0.0012
631 NEUTROPHILIA 7 0.0012
632 RED BLOOD CELL COUNT DECREASED 35 0.0012
633 MYOCARDITIS 14 0.0012
634 IMMUNE SYSTEM DISORDER 16 0.0012
635 BONE PAIN 71 0.0012
636 VENTRICULAR TACHYCARDIA 20 0.0012
637 TREATMENT FAILURE 100 0.0012
638 THERAPEUTIC PRODUCT EFFECT DECREASED 54 0.0012
639 RESPIRATORY DISTRESS 33 0.0012
640 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 35 0.0012
641 ABSCESS 19 0.0012
642 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
643 PULMONARY OEDEMA 53 0.0012
644 TACHYPNOEA 16 0.0012
645 PNEUMONIA ASPIRATION 29 0.0012
646 NERVOUS SYSTEM DISORDER 36 0.0012
647 HEPATIC FUNCTION ABNORMAL 43 0.0012
648 PLATELET COUNT INCREASED 15 0.0011
649 LIVER INJURY 28 0.0011
650 ANAPHYLACTIC REACTION 63 0.0011
651 PRODUCT USE ISSUE 213 0.0011
652 RENAL CYST 9 0.0011
653 TRICUSPID VALVE INCOMPETENCE 9 0.0011
654 ORAL HERPES 22 0.0011
655 RASH PRURITIC 61 0.0011
656 WHITE BLOOD CELL COUNT INCREASED 43 0.0011
657 ARRHYTHMIA 53 0.0011
658 CIRCULATORY COLLAPSE 19 0.0011
659 SYNOVITIS 20 0.0011
660 OEDEMA 60 0.0011
661 THERAPEUTIC RESPONSE DECREASED 67 0.0011
662 OESOPHAGITIS 12 0.0011
663 PATHOGEN RESISTANCE 10 0.0011
664 METASTASES TO CENTRAL NERVOUS SYSTEM 14 0.0011
665 TOOTH ABSCESS 11 0.0011
666 BLOOD UREA INCREASED 18 0.0011
667 PULMONARY MASS 16 0.0011
668 ERYTHEMA MULTIFORME 10 0.0011
669 NO THERAPEUTIC RESPONSE 13 0.0011
670 STATUS EPILEPTICUS 12 0.0011
671 LEUKAEMIA 10 0.0011
672 DEHYDRATION 141 0.0011
673 INFLAMMATION 54 0.0010
674 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
675 GASTROINTESTINAL INFLAMMATION 8 0.0010
676 RENAL FAILURE ACUTE 43 0.0010
677 FACE OEDEMA 17 0.0010
678 LARGE INTESTINE PERFORATION 7 0.0010
679 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
680 SKIN ULCER 26 0.0010
681 HIATUS HERNIA 13 0.0010
682 HAEMORRHAGE INTRACRANIAL 15 0.0010
683 MYOSITIS 9 0.0010
684 HYPONATRAEMIA 56 0.0010
685 DELIRIUM 34 0.0010
686 RASH 425 0.0010
687 HICCUPS 8 0.0010
688 CARDIAC ARREST 80 0.0010
689 TACHYCARDIA 86 0.0010
690 PULMONARY HYPERTENSION 20 0.0010
691 GASTROINTESTINAL DISORDER 86 0.0010
692 URINARY RETENTION 32 0.0010
693 FOLLICULITIS 10 0.0010
694 SYNCOPE 95 0.0009
695 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 22 0.0009
696 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 67 0.0009
697 COLON CANCER 14 0.0009
698 SPINAL PAIN 11 0.0009
699 HAEMODYNAMIC INSTABILITY 7 0.0009
700 SINUS TACHYCARDIA 13 0.0009
701 SPINAL OSTEOARTHRITIS 8 0.0009
702 SARS-COV-2 TEST POSITIVE 12 0.0009
703 ATRIOVENTRICULAR BLOCK 7 0.0009
704 MENTAL STATUS CHANGES 25 0.0009
705 PROTEINURIA 17 0.0009
706 MUSCULOSKELETAL DISORDER 17 0.0009
707 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
708 EYE INFECTION 10 0.0009
709 ABDOMINAL PAIN 204 0.0009
710 GASTRITIS 23 0.0009
711 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
712 CELLULITIS 44 0.0009
713 HYPERSENSITIVITY 160 0.0009
714 HEPATIC CIRRHOSIS 16 0.0009
715 EPILEPSY 26 0.0008
716 DYSPNOEA EXERTIONAL 32 0.0008
717 COAGULOPATHY 14 0.0008
718 EOSINOPHIL COUNT INCREASED 7 0.0008
719 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
720 CEREBRAL HAEMORRHAGE 30 0.0008
721 BRONCHITIS 62 0.0008
722 GOUT 15 0.0008
723 BLINDNESS 34 0.0008
724 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
725 DIVERTICULITIS 23 0.0008
726 HYPERTHYROIDISM 12 0.0008
727 SHOCK 19 0.0008
728 DEATH 708 0.0008
729 URINARY TRACT INFECTION 140 0.0008
730 CEREBRAL INFARCTION 20 0.0008
731 SCAR 14 0.0008
732 ANURIA 7 0.0008
733 DYSPHAGIA 77 0.0008
734 HAEMATOMA 21 0.0008
735 MOUTH ULCERATION 17 0.0008
736 TOXICITY TO VARIOUS AGENTS 136 0.0008
737 DIARRHOEA 519 0.0008
738 BLOOD CALCIUM INCREASED 7 0.0008
739 DRUG-INDUCED LIVER INJURY 25 0.0008
740 INTESTINAL OBSTRUCTION 30 0.0008
741 PERITONITIS BACTERIAL 8 0.0008
742 ANAL INCONTINENCE 7 0.0008
743 PERITONITIS 16 0.0008
744 RASH GENERALISED 20 0.0008
745 OPTIC NEURITIS 7 0.0008
746 HEMIPARESIS 13 0.0008
747 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40 0.0008
748 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
749 RASH PAPULAR 17 0.0008
750 SUDDEN DEATH 8 0.0008
751 ABDOMINAL PAIN LOWER 19 0.0008
752 APPENDICITIS 7 0.0007
753 HEPATIC ENZYME INCREASED 51 0.0007
754 DRUG INEFFECTIVE 985 0.0007
755 DECREASED APPETITE 172 0.0007
756 HAEMORRHAGE 77 0.0007
757 SKIN DISORDER 24 0.0007
758 AUTOIMMUNE DISORDER 7 0.0007
759 WEIGHT DECREASED 200 0.0007
760 VOMITING 336 0.0007
761 CONSTIPATION 154 0.0007
762 MYOCARDIAL ISCHAEMIA 8 0.0007
763 HAEMATURIA 24 0.0007
764 THROMBOSIS 56 0.0007
765 APHASIA 21 0.0007
766 METASTASES TO LUNG 8 0.0007
767 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
768 PANCREATITIS ACUTE 15 0.0007
769 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
770 OEDEMA PERIPHERAL 81 0.0007
771 SINUSITIS 68 0.0007
772 BLOOD PRESSURE DECREASED 44 0.0007
773 NEURALGIA 16 0.0007
774 LIVER FUNCTION TEST ABNORMAL 19 0.0007
775 DYSPNOEA 366 0.0006
776 PHARYNGITIS 8 0.0006
777 NEOPLASM MALIGNANT 43 0.0006
778 ASTHENIA 242 0.0006
779 CONFUSIONAL STATE 104 0.0006
780 ERYTHEMA 132 0.0006
781 BRAIN OEDEMA 8 0.0006
782 BLOOD URINE PRESENT 12 0.0006
783 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
784 CARDIOGENIC SHOCK 9 0.0006
785 COUGH 175 0.0006
786 BLOOD CALCIUM DECREASED 7 0.0006
787 FLUID OVERLOAD 9 0.0006
788 HAEMORRHOIDS 12 0.0006
789 EATING DISORDER 13 0.0006
790 OSTEONECROSIS 20 0.0006
791 PRODUCTIVE COUGH 29 0.0006
792 TOOTH INFECTION 8 0.0006
793 RASH ERYTHEMATOUS 29 0.0006
794 RENAL INJURY 18 0.0006
795 OXYGEN SATURATION DECREASED 34 0.0006
796 OSTEOPENIA 9 0.0006
797 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
798 INFLUENZA 65 0.0006
799 DRUG EFFECT INCOMPLETE 21 0.0006
800 HAEMOPTYSIS 16 0.0006
801 HYPERTENSION 121 0.0006
802 CARDIOMEGALY 7 0.0006
803 SEASONAL ALLERGY 8 0.0006
804 FATIGUE 438 0.0006
805 GASTROINTESTINAL HAEMORRHAGE 47 0.0006
806 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
807 CORONARY ARTERY DISEASE 17 0.0006
808 PEMPHIGUS 7 0.0006
809 PROSTATE CANCER 45 0.0006
810 ANGINA PECTORIS 16 0.0006
811 NO ADVERSE EVENT 101 0.0006
812 SKIN CANCER 12 0.0006
813 DISORIENTATION 22 0.0006
814 CHOLELITHIASIS 18 0.0005
815 URTICARIA 90 0.0005
816 NAUSEA 425 0.0005
817 RESPIRATORY DISORDER 16 0.0005
818 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
819 MUSCULAR WEAKNESS 60 0.0005
820 GASTRIC ULCER 10 0.0005
821 OSTEONECROSIS OF JAW 13 0.0005
822 ARTHROPATHY 29 0.0005
823 ANGIOEDEMA 23 0.0005
824 ORTHOSTATIC HYPOTENSION 9 0.0005
825 RECTAL HAEMORRHAGE 22 0.0005
826 LUNG NEOPLASM MALIGNANT 21 0.0005
827 BRADYCARDIA 27 0.0005
828 TINNITUS 23 0.0005
829 PARALYSIS 7 0.0005
830 PERICARDITIS 8 0.0005
831 VERTIGO 29 0.0005
832 TYPE 2 DIABETES MELLITUS 16 0.0005
833 CARDIAC FAILURE CONGESTIVE 38 0.0005
834 PANCREATITIS 25 0.0005
835 EPISTAXIS 35 0.0005
836 CONDITION AGGRAVATED 142 0.0005
837 FEELING COLD 13 0.0005
838 BLOOD POTASSIUM DECREASED 14 0.0005
839 DYSURIA 17 0.0005
840 BLOOD COUNT ABNORMAL 7 0.0005
841 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
842 PRESYNCOPE 11 0.0005
843 MENINGIOMA 7 0.0004
844 PRURITUS 169 0.0004
845 CARDIOVASCULAR DISORDER 11 0.0004
846 LACTIC ACIDOSIS 14 0.0004
847 RENAL DISORDER 20 0.0004
848 DYSARTHRIA 16 0.0004
849 IMPAIRED WORK ABILITY 9 0.0004
850 DRY EYE 21 0.0004
851 PARAESTHESIA 66 0.0004
852 PALPITATIONS 49 0.0004
853 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
854 MELAENA 9 0.0004
855 RESPIRATORY ARREST 11 0.0004
856 UNDERDOSE 29 0.0004
857 FULL BLOOD COUNT DECREASED 8 0.0004
858 CARDIAC DISORDER 37 0.0004
859 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
860 MYALGIA 67 0.0004
861 BACK PAIN 90 0.0004
862 OSTEOMYELITIS 7 0.0004
863 SPEECH DISORDER 20 0.0004
864 CHRONIC KIDNEY DISEASE 29 0.0004
865 CHEST DISCOMFORT 39 0.0004
866 HYPOTHYROIDISM 12 0.0004
867 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
868 CHEST PAIN 69 0.0004
869 SKIN EXFOLIATION 31 0.0004
870 MUSCULOSKELETAL PAIN 19 0.0004
871 HERNIA 7 0.0004
872 EAR PAIN 7 0.0004
873 ARTHRITIS 28 0.0004
874 GASTRIC CANCER 9 0.0004
875 DIPLOPIA 9 0.0003
876 METABOLIC ACIDOSIS 11 0.0003
877 EAR INFECTION 9 0.0003
878 SWELLING FACE 22 0.0003
879 DYSPEPSIA 33 0.0003
880 HYPERHIDROSIS 43 0.0003
881 INFLUENZA LIKE ILLNESS 27 0.0003
882 LIVER FUNCTION TEST INCREASED 7 0.0003
883 PERIPHERAL SWELLING 49 0.0003
884 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
885 LOSS OF CONSCIOUSNESS 40 0.0003
886 CARDIO-RESPIRATORY ARREST 13 0.0003
887 SWELLING 29 0.0003
888 MYOCARDIAL INFARCTION 54 0.0003
889 LABORATORY TEST ABNORMAL 9 0.0003
890 PSYCHOTIC DISORDER 9 0.0003
891 NECK PAIN 17 0.0003
892 URINARY INCONTINENCE 9 0.0003
893 ARTHRALGIA 123 0.0003
894 ADVERSE EVENT 27 0.0003
895 OROPHARYNGEAL PAIN 27 0.0003
896 MUSCULOSKELETAL STIFFNESS 25 0.0003
897 BLISTER 16 0.0003
898 HYPERSOMNIA 8 0.0003
899 UNEVALUABLE EVENT 21 0.0003
900 MENTAL DISORDER 12 0.0003
901 IMPAIRED HEALING 9 0.0003
902 HYPOPHAGIA 7 0.0003
903 DYSGEUSIA 20 0.0003
904 SEIZURE 31 0.0003
905 ROAD TRAFFIC ACCIDENT 11 0.0003
906 ABDOMINAL DISTENSION 27 0.0003
907 PALLOR 7 0.0003
908 HEAD INJURY 8 0.0003
909 CATARACT 15 0.0003
910 DEMENTIA 7 0.0003
911 TREMOR 41 0.0002
912 FALL 82 0.0002
913 LETHARGY 14 0.0002
914 HEADACHE 152 0.0002
915 SLEEP DISORDER 17 0.0002
916 DRUG INTERACTION 38 0.0002
917 PAIN 146 0.0002
918 CEREBROVASCULAR ACCIDENT 40 0.0002
919 COGNITIVE DISORDER 11 0.0002
920 ALOPECIA 46 0.0002
921 MALAISE 99 0.0002
922 WHEEZING 13 0.0002
923 RESTLESSNESS 8 0.0002
924 FLUSHING 22 0.0002
925 INSOMNIA 57 0.0002
926 HYPOAESTHESIA 32 0.0002
927 CONTUSION 20 0.0002
928 DEPRESSION 47 0.0002
929 NASOPHARYNGITIS 38 0.0002
930 ABDOMINAL PAIN UPPER 42 0.0002
931 DISTURBANCE IN ATTENTION 11 0.0002
932 RHEUMATOID ARTHRITIS 23 0.0002
933 HEART RATE INCREASED 20 0.0002
934 SOMNOLENCE 40 0.0002
935 PAIN IN EXTREMITY 58 0.0002
936 DISCOMFORT 12 0.0002
937 MEMORY IMPAIRMENT 27 0.0002
938 VISUAL IMPAIRMENT 24 0.0002
939 POLLAKIURIA 8 0.0002
940 JOINT SWELLING 23 0.0002
941 COMA 9 0.0002
942 INJECTION SITE REACTION 13 0.0002
943 RENAL CANCER 9 0.0002
944 DYSPHONIA 11 0.0002
945 BLADDER CANCER 11 0.0002
946 DIZZINESS 93 0.0002
947 DIABETES MELLITUS 14 0.0002
948 TREATMENT NONCOMPLIANCE 10 0.0002
949 OVERDOSE 39 0.0002
950 FEELING HOT 11 0.0002
951 ECZEMA 9 0.0002
952 RHINORRHOEA 11 0.0002
953 OCULAR HYPERAEMIA 8 0.0002
954 AGITATION 12 0.0002
955 HYPOACUSIS 7 0.0002
956 DRY MOUTH 13 0.0002
957 MUSCLE SPASMS 29 0.0002
958 FLUID RETENTION 8 0.0002
959 THERAPY CESSATION 8 0.0002
960 WEIGHT INCREASED 32 0.0001
961 BLOOD PRESSURE INCREASED 21 0.0001
962 ABDOMINAL DISCOMFORT 23 0.0001
963 HALLUCINATION 10 0.0001
964 GAIT DISTURBANCE 25 0.0001
965 BREAST CANCER 12 0.0001
966 EXPOSURE DURING PREGNANCY 8 0.0001
967 HAEMATOCHEZIA 7 0.0001
968 MOBILITY DECREASED 9 0.0001
969 FLATULENCE 7 0.0001
970 CONVULSION 7 0.0001
971 NASAL CONGESTION 7 0.0001
972 BALANCE DISORDER 10 0.0001
973 BLOOD GLUCOSE INCREASED 21 0.0001
974 DRY SKIN 14 0.0001
975 INJECTION SITE ERYTHEMA 13 0.0001
976 FEELING ABNORMAL 25 0.0001
977 VISION BLURRED 14 0.0001
978 ANXIETY 29 0.0001
979 ADVERSE DRUG REACTION 9 0.0001
980 ILLNESS 10 0.0001
981 PSORIASIS 12 0.0001
982 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
983 HOSPITALISATION 12 0.0001
984 INJECTION SITE PAIN 15 0.0000
985 INCORRECT DOSE ADMINISTERED 11 0.0000
986 PRODUCT DOSE OMISSION ISSUE 9 0.0000